Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To compare the direct effect of sodium acetate ringer injection or albumin on volume expansion in shock patients, and to provide reference for volume resuscitation strategy in shock patients
CI/SVI increase amplitude and maintenance time
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| sodium acetate ringer | Experimental |
| |
| albumin | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Compound sodium acetate ringer injection | Drug | Quickly infuse 500ml of compound sodium acetate ringer injection for volume expansion within 20-30 minutes |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of Cardiac output Index(CI) change | The changes of cardiac output index before and after volume expansion were compared | 2 hour |
| Percentage of Stroke Volume Index(SVI)change | The changes of Stroke Volume Index before and after volume expansion were compared | 2 hour |
| Measure | Description | Time Frame |
|---|---|---|
| Duration of Cardiac output Index(CI) change | The duration of cardiac output index changes before and after volume expansion was compared | 2 hour |
| Duration of Stroke Volume Index(SVI)change | The duration of Stroke Volume Index changes before and after volume expansion was compared |
Not provided
Inclusion Criteria:
Age ≥ 18 years old, gender unlimited
Shock requires volume resuscitation:
Insufficient tissue perfusion: wet and cold skin, decreased urine volume (<0.5ml/kg/h), change of consciousness, blood lactate >2.0mmol/l or vasoactive drugs are required to maintain map>65mmhg
Presence of volume reactivity: (under controlled ventilation) PPV ≥ 15% or passive leg raising test (+) or (under controlled ventilation) IVC variability ≥ 18% or the presence of volume reactivity as judged by clinicians
The patient has no obvious restlessness, RASS ≤ 0
The legal representative of the subject signs the informed consent form-
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Yun Long, doctor | Contact | 86-010-69152300 | ly_icu@aliyun.com |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012769 | Shock |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000418 | Albumins |
| ID | Term |
|---|---|
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Albumin | Drug | Quickly infuse 500ml of albumin for volume expansion within 20-30 minutes |
|
| 2 hour |